共伴侣蛋白P23通过调控GPX4稳定性抑制脓毒症相关急性肾损伤中的铁死亡
该研究在体内和体外模型中探讨脓毒症相关急性肾损伤(SA-AKI)中GPX4减少的分子机制。研究发现RNA结合蛋白P23在SA-AKI中表达显著上调,并作为铁死亡的关键抑制因子发挥作用。药理抑制P23(celastrol)加重肾功能障碍和铁死亡损伤,表现为脂质过氧化升高、铁超载和GPX4下调;P23过表达则通过稳定GPX4 mRNA减轻铁死亡。RIP和免疫共沉淀显示P23直接结合GPX4 mRNA和蛋白形成保护性复合物。
要点
- 在SA-AKI体内和体外模型中P23表达显著上调,并作为铁死亡的关键抑制因子。
- 药理学抑制P23(celastrol)加重肾功能障碍和铁死亡损伤,表现为脂质过氧化升高、铁超载和GPX4下调。
- P23过表达通过稳定GPX4 mRNA减轻铁死亡,维持GPX4蛋白水平和氧化还原稳态。
- RIP和免疫共沉淀显示P23直接结合GPX4 mRNA和蛋白,形成保护性复合物,阻碍mRNA降解和铁死亡级联。
- P23的RNA结合活性被视为减轻SA-AKI的可治疗靶点机制。
研究设计与关键结果
- 研究类型为整合体内和体外模型的基础研究,探讨P23在SA-AKI中对铁死亡的调控机制。
- P23在SA-AKI中表达显著上调,作为铁死亡的关键抑制因子。
- 药理学抑制P23(celastrol)加重肾功能障碍和铁死亡损伤,表现为脂质过氧化升高、铁超载和GPX4下调。
- P23过表达通过稳定GPX4 mRNA减轻铁死亡,维持GPX4蛋白水平和氧化还原稳态。
- RIP和免疫共沉淀显示P23直接结合GPX4 mRNA和蛋白,形成保护性复合物,阻碍mRNA降解和铁死亡级联。
证据类型、等级与局限
- 证据类型:基础研究(体内和体外模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为P23的RNA结合活性是可治疗靶点机制,为开发以P23为中心的干预措施对抗脓毒症中铁死亡驱动的肾损伤提供基础。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Ferroptosis, an iron-dependent form of regulated cell death, has been implicated in severe kidney diseases, particularly those characterized by the depletion of GPX4. Despite its clinical significance, the molecular mechanisms driving GPX4 reduction in SA-AKI remain poorly understood. In this study, we uncover a novel regulatory axis involving the RNA-binding protein P23 and GPX4 mRNA stability in SA-AKI pathogenesis. Using integrated in vivo and in vitro models, we demonstrate that P23 expression is significantly upregulated during SA-AKI and functions as a critical suppressor of ferroptosis. Mechanistically, pharmacological inhibition of P23 with celastrol exacerbated renal dysfunction and amplified ferroptotic damage, as evidenced by elevated lipid peroxidation, iron overload, and GPX4 downregulation. Conversely, P23 overexpression robustly attenuated ferroptosis by stabilizing GPX4 mRNA, thereby preserving GPX4 protein levels and redox homeostasis. Crucially, RIP and Co-immunoprecipitation assays revealed that P23 directly binds to GPX4 mRNA and protein, forming a protective complex that impedes mRNA degradation and ferroptotic cascades. These findings establish P23 as a multifunctional regulator of ferroptosis and highlight its RNA-binding activity as a therapeutically targetable mechanism for mitigating SA-AKI. Our work provides a foundation for developing P23-centric interventions to combat ferroptosis-driven kidney injury in sepsis.
参考来源
- Luo M, Xu Q, Sun Y, et al. CO-CHAPERONE P23 INHIBITS FERROPTOSIS IN SEPSIS-ASSOCIATED ACUTE KIDNEY INJURY BY REGULATING GPX4 STABILITY. Shock. 2025. PMID: 40333430. doi:10.1097/SHK.0000000000002623
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。